ATE408144T1 - Assays - Google Patents
AssaysInfo
- Publication number
- ATE408144T1 ATE408144T1 AT01977000T AT01977000T ATE408144T1 AT E408144 T1 ATE408144 T1 AT E408144T1 AT 01977000 T AT01977000 T AT 01977000T AT 01977000 T AT01977000 T AT 01977000T AT E408144 T1 ATE408144 T1 AT E408144T1
- Authority
- AT
- Austria
- Prior art keywords
- assays
- bam
- agonists
- antagonists
- rat
- Prior art date
Links
- 238000003556 assay Methods 0.000 title abstract 3
- 239000000556 agonist Substances 0.000 abstract 2
- 241000283690 Bos taurus Species 0.000 abstract 1
- 210000001943 adrenal medulla Anatomy 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24088900P | 2000-10-17 | 2000-10-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE408144T1 true ATE408144T1 (de) | 2008-09-15 |
Family
ID=22908344
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01977000T ATE408144T1 (de) | 2000-10-17 | 2001-10-16 | Assays |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7270965B2 (de) |
| EP (1) | EP1334362B1 (de) |
| JP (1) | JP2004511806A (de) |
| AT (1) | ATE408144T1 (de) |
| AU (1) | AU2001296150A1 (de) |
| CA (1) | CA2423596A1 (de) |
| DE (1) | DE60135773D1 (de) |
| ES (1) | ES2311551T3 (de) |
| WO (1) | WO2002033416A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004111642A2 (en) * | 2003-06-16 | 2004-12-23 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with sensory neuron-specific g protein-coupled receptor 1 (snsr1) |
| WO2005003762A2 (en) * | 2003-06-17 | 2005-01-13 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with sensory neuron-specific g protein-coupled receptor 2 (snsr2) |
| WO2005003763A2 (en) * | 2003-06-18 | 2005-01-13 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with mas related g-protein coupled receptor 3 (mrgx3) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4388236A (en) * | 1979-08-30 | 1983-06-14 | Hoffmann-La Roche Inc. | Enkephalin-like compounds in bovine adrenal medulla |
| US5367053A (en) * | 1993-05-19 | 1994-11-22 | Houghten Pharmaceuticals, Inc. | Opioid peptide inhibitors |
| SE9704836D0 (sv) | 1997-12-22 | 1997-12-22 | Astra Pharma Inc | Novel receptor |
| CA2344459A1 (en) * | 1998-10-01 | 2000-04-13 | Takeda Chemical Industries, Ltd. | Novel g protein-coupled receptor protein and dna thereof |
| DE60115878T2 (de) | 2000-05-04 | 2006-08-24 | California Institute Of Technology, Pasadena | Schmerz signalisierende moleküle |
-
2001
- 2001-10-16 EP EP01977000A patent/EP1334362B1/de not_active Expired - Lifetime
- 2001-10-16 AU AU2001296150A patent/AU2001296150A1/en not_active Abandoned
- 2001-10-16 US US10/399,181 patent/US7270965B2/en not_active Expired - Fee Related
- 2001-10-16 AT AT01977000T patent/ATE408144T1/de not_active IP Right Cessation
- 2001-10-16 ES ES01977000T patent/ES2311551T3/es not_active Expired - Lifetime
- 2001-10-16 CA CA002423596A patent/CA2423596A1/en not_active Abandoned
- 2001-10-16 WO PCT/SE2001/002264 patent/WO2002033416A1/en not_active Ceased
- 2001-10-16 JP JP2002536552A patent/JP2004511806A/ja active Pending
- 2001-10-16 DE DE60135773T patent/DE60135773D1/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE60135773D1 (en) | 2008-10-23 |
| EP1334362A1 (de) | 2003-08-13 |
| EP1334362B1 (de) | 2008-09-10 |
| JP2004511806A (ja) | 2004-04-15 |
| ES2311551T3 (es) | 2009-02-16 |
| US7270965B2 (en) | 2007-09-18 |
| CA2423596A1 (en) | 2002-04-25 |
| US20050059575A1 (en) | 2005-03-17 |
| AU2001296150A1 (en) | 2002-04-29 |
| WO2002033416A1 (en) | 2002-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG149693A1 (en) | Peptides acting as both glp-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use | |
| EA200101177A1 (ru) | Производные индола в качестве антагонистов прогестерона | |
| TR199801679T2 (xx) | Osteoporoz i�in birle�tirme terapisi. | |
| DE69942753D1 (de) | Peptidantagonist von Zonulin und dessen Verwendung | |
| NO922457L (no) | Antistoffantagonister av humant interleukin-4 | |
| EA200300441A1 (ru) | Ассоциация антагониста рецептора св1 и сибутрамина, содержащие их фармацевтические композиции и их применение для лечения ожирения | |
| WO2001081408A3 (en) | G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same | |
| EP1432433A4 (de) | Antagonisten | |
| DK1023074T3 (da) | Fremgangsmåder til behandling af psykose forbundet med glucocorticoid-relateret dysfunktion | |
| SG166090A1 (en) | Il-13 binding agents | |
| PT1066380E (pt) | Receptor de celula t soluvel | |
| EA200201119A1 (ru) | Лиганды меланокортиновых рецепторов | |
| ATE521599T1 (de) | Heterocyclische modulatoren von nukleären rezeptoren | |
| DK1411916T3 (da) | Fremgangsmåder og materialer til behandling af testosteronmangel hos mænd | |
| ATE306272T1 (de) | Verwendung von einem aldosteron-rezeptor- antagonisten zur verbesserung der kognitiven funktion | |
| TR200102041T2 (tr) | Progesteron reseptör bağlama aktif maddeleri olarak ikameli 2-arilimino heterosaykıllar | |
| UA87122C2 (ru) | Агонисты рецепторов глюкагонподобного пептида-1, их применение и способ получения | |
| TR199902399T2 (xx) | Bir asfalt bile�imi haz�rlamak i�in i�lem. | |
| ATE408144T1 (de) | Assays | |
| TR200200357T2 (tr) | Yeni integrin reseptör antagonistleri | |
| DK1022636T3 (da) | Blandingsarmatur med etgrebsbetjening | |
| NO20006320L (no) | Cykliske somatostatin-analoger | |
| ATE273389T1 (de) | Rezeptor des y-y5 neuropeptids | |
| SE9904660D0 (sv) | Novel assays | |
| ATE441642T1 (de) | Hydantoin derivate mit affinität für somatostatin rezeptoren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |